Skip to main content
Bayer AG logo

Bayer AG — Investor Relations & Filings

Ticker · BAY ISIN · DE000BAY0017 LEI · 549300J4U55H3WP1XT59 F Manufacturing
Open in API
Filings indexed 365 across all filing types
Latest filing 2019-02-20 Report Publication Anno…
Country DE Germany
Listing F BAY

About Bayer AG

https://www.bayer.com/en/

Bayer AG is a global life science company with core competencies in the fields of healthcare and nutrition. Guided by its mission "Health for all, Hunger for none," the company develops products and services to address fundamental human needs and global challenges. Its operations are divided into three main divisions: Pharmaceuticals, which focuses on prescription products; Consumer Health, which offers over-the-counter medications and supplements; and Crop Science, which provides tailored solutions for farmers including seeds, crop protection, and digital farming technologies. Bayer's activities encompass the discovery, development, manufacturing, and commercialization of its product portfolio, aiming to improve quality of life and ensure a sustainable supply of food and feed.

Recent filings

Filing Released Lang Actions
Hinweis auf Jahresfinanzbericht vom 01.01.2018 bis zum 31.12.2018
Report Publication Announcement Classification · 100% confidence The document is a short notification (771 characters) informing stakeholders that the 2018 Annual Financial Report is available online. It provides a link to the report and specifies the publication date. Per the 'Menu vs Meal' rule, since this is an announcement of a report's availability rather than the report itself, it is classified as a Report Publication Announcement (RPA).
2019-02-20 German
Datum:20.02.2019
Report Publication Announcement Classification · 100% confidence The document is a short notification (756 characters) informing stakeholders that the Annual Financial Report for 2018 is available online. It provides a link to the report and specifies the publication date. Per the 'Menu vs Meal' rule, since this is an announcement of a report's availability rather than the report itself, it is classified as a Report Publication Announcement (RPA).
2019-02-20 German
§§ 264 Abs. 3, 325 HGB zum Geschäftsjahr vom 01.01.2018 bis zum 31.12.2018
Audit Report / Information Classification · 95% confidence The document is a formal notification from Bayer AG regarding the application of relief provisions under § 264 Abs. 3 HGB for its subsidiaries for the 2018 fiscal year. It confirms that these subsidiaries are included in the consolidated financial statements of Bayer AG and that profit transfer agreements are in place. This is a regulatory disclosure required by German commercial law (HGB) to inform the public about the exemption from publishing individual financial statements for subsidiaries. It does not contain financial results, management reports, or meeting materials, but rather serves as a formal regulatory filing. FY 2018
2018-12-20 German
Q3 statement / Q3 financial report 2018
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Interim Report Third Quarter of 2018' and contains comprehensive financial data, including consolidated income statements, statements of financial position, and management discussion and analysis. It is a formal quarterly financial report for the Bayer Group, which fits the definition of an Interim/Quarterly Report (IR). Q3 2018
2018-11-13 English
Bekanntmachung gemäß §§ 264 Abs. 3, 325 HGB zum Geschäftsjahr vom 01.01.2018 bis 31.12.2018
Audit Report / Information Classification · 95% confidence The document is a formal announcement published in the German Federal Gazette (Bundesanzeiger) regarding the exemption of subsidiaries (Bayer CropScience) from individual financial statement disclosure requirements under § 264 Abs. 3 HGB, as they are included in the consolidated financial statements of the parent company, Bayer AG. It also includes a voluntary guarantee declaration. Since this is a regulatory notification regarding financial reporting compliance and disclosure status rather than a financial report itself, it falls under the category of general regulatory filings. FY 2018
2018-11-12 German
Halbjahresfinanzbericht
Interim / Quarterly Report Classification · 100% confidence The document is a 'Zwischenbericht' (Interim Report) for Bayer AG for the second quarter of 2018. It contains detailed financial performance data, including revenue, EBITDA, EBIT, and segment-specific analysis (Pharmaceuticals, Consumer Health, Crop Science, Animal Health). It also discusses corporate events such as the Monsanto acquisition and capital measures. As it provides comprehensive financial statements and analysis for a period shorter than a full fiscal year, it is classified as an Interim/Quarterly Report. Q2 2018
2018-09-05 German

Browse filings by year

24 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.